Drugs Controller General of India (DCGI) V.G. Somani has gave permission to Serum Institute of India (SII) to resume medical trial of the Oxford COVID-19 vaccine prospect in the nation while revok …
Read More
Serum Institute gets DCGI nod to resume medical trial of Oxford COVID-19 vaccine
Byindianadmin
Sep 16, 2020